Genovate Biotechnology Co., Ltd. (TPEX:4130)

Taiwan · Delayed Price · Currency is TWD

30.95

+0.60 (1.98%)

Mar 24, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	492.41M	510.86M	528.51M	438.76M	434.25M
Pharmaceuticals Growth	-3.61%	-3.34%	20.46%	1.04%	-8.14%
Total	492.41M	510.86M	528.51M	438.76M	434.25M
Total Growth	-3.61%	-3.34%	20.46%	1.04%	-8.14%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan	483.82M	505.74M	519.35M	435.22M	429.86M
Taiwan Growth	-4.33%	-2.62%	19.33%	1.25%	-7.96%
Other	8.58M	5.12M	9.16M	3.54M	4.40M
Other Growth	67.58%	-44.10%	158.64%	-19.48%	-22.70%
Total	492.41M	510.86M	528.51M	438.76M	434.25M
Total Growth	-3.61%	-3.34%	20.46%	1.04%	-8.14%

Source: S&P Global Market Intelligence.